About Viz.ai
Viz.ai is a company based in San Francisco (United States) founded in 2016 by Chris Mansi and David Golan.. Viz.ai has raised $251.99 million across 7 funding rounds from investors including Canadian Imperial Bank of Commerce, Kleiner Perkins and Seedcamp. Viz.ai offers products and services including Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite. Viz.ai operates in a competitive market with competitors including AIdoc, PathAI, Perspectum, Deepcell and Qure.ai, among others.
- Headquarter San Francisco, United States
- Founders Chris Mansi, David Golan
- Stage Unicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Viz.Ai
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$251.99 M (USD)
in 7 rounds
-
Latest Funding Round
$40 M (USD), Debt – Conventional
Mar 22, 2023
-
Investors
Canadian Imperial Bank of Commerce
& 15 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viz.ai
Viz.ai offers a comprehensive portfolio of products and services, including Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI solution for detecting and coordinating treatments across diseases.
AI tools for identifying strokes and aneurysms in medical imaging.
Platform for pulmonary embolism and aortic disease analysis.
AI for hypertrophic cardiomyopathy and post-stroke care.
AI to accelerate diagnosis in radiology workflows.
Unlock access to complete
Unlock access to complete
Leadership Team
16 people
Human Resources and Administration
9 people
Senior Team
6 people
Software Development Team
6 people
Data Analysis and Operations Team
5 people
Clinical Team
4 people
Board Team
4 people
Sales and Marketing
3 people
Unlock access to complete
Funding Insights of Viz.ai
Viz.ai has successfully raised a total of $251.99M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $40 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Debt – Conventional — $40.0M
-
First Round
First Round
(15 Sep 2016)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Debt – Conventional - Viz.ai | Valuation |
investors |
|
| Apr, 2022 | Amount | Series D - Viz.ai | Valuation | Tiger Global Management , Insight Partners | |
| Mar, 2021 | Amount | Series C - Viz.ai | Valuation | Scale Venture Partners , Insight Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Viz.ai
Viz.ai has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, Kleiner Perkins and Seedcamp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture and private equity investments are managed with global diversification.
|
Founded Year | Domain | Location | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are focused on US companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Viz.ai
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Viz.ai
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Viz.Ai Comparisons
Competitors of Viz.ai
Viz.ai operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, PathAI, Perspectum, Deepcell and Qure.ai, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Precision medicine software for liver disease diagnosis is offered.
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
AI-powered solutions for medical imaging diagnostics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Viz.Ai
Frequently Asked Questions about Viz.ai
When was Viz.ai founded?
Viz.ai was founded in 2016.
Where is Viz.ai located?
Viz.ai is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Viz.ai?
Chris Mansi is the current CEO of Viz.ai. They have also founded this company.
Is Viz.ai a funded company?
Viz.ai is a funded company, having raised a total of $251.99M across 7 funding rounds to date. The company's 1st funding round was a Series C of $71M, raised on Sep 15, 2016.
What does Viz.ai do?
Viz.ai was founded in 2016 in San Francisco, United States, within the healthcare technology sector. AI-driven care coordination software is provided for stroke diagnosis and neurology support. Emergency medical cases are addressed through tools that compare patient scans to databases, identifying patterns for conditions. Scans are categorized into types to aid clinical decisions, with operations centered on cloud-based platforms.
Who are the top competitors of Viz.ai?
Viz.ai's top competitors include Perspectum, Qure.ai and AIdoc.
What products or services does Viz.ai offer?
Viz.ai offers Viz.ai One, Viz Neuro Suite, Viz Vascular Suite, Viz Cardio Suite, and Viz Radiology Suite.
Who are Viz.ai's investors?
Viz.ai has 16 investors. Key investors include Canadian Imperial Bank of Commerce, Kleiner Perkins, Seedcamp, Pear VC, and Tiger Global.
What is Viz.ai's valuation?
The valuation of Viz.ai is $1.2B as of Apr 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.